Estados financieros detallados de Cue Biopharma, Inc. (CUE): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Cue Biopharma, Inc. registró ingresos de $27.5M en el último ejercicio fiscal, con un CAGR de 5 años del 54.2%.
Márgenes de los últimos 12 meses: margen bruto 100.0%, margen operativo -96.6%, margen neto -96.9%.
Al precio actual de $34.17, CUE presenta beneficios negativos (P/E no significativo) y un ROE del -100.64%. La capitalización bursátil es de $90M.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | 0 | 0 | $1.1M | $3.5M | $3.2M | $14.9M | $1.2M | $5.5M | $9.3M | $27.5M |
| Coste de Ventas | $202085 | $419568 | $28.5M | $27.5M | $33.5M | -$1.8M | 0 | $38.1M | 0 | 0 |
| Beneficio Bruto | -$202085 | -$419568 | -$27.4M | -$24.0M | -$30.4M | $16.7M | $1.2M | -$32.6M | $9.3M | $27.5M |
| I+D | $5.7M | $18.9M | $28.5M | $27.5M | $33.5M | $41.3M | $38.6M | $40.8M | $36.3M | $37.7M |
| Generales y Administrativos | $2.0M | $4.3M | $11.3M | $12.7M | $14.7M | $17.3M | $16.2M | $16.7M | $14.6M | $16.2M |
| Gastos Operativos | $7.7M | $23.2M | $39.8M | $12.7M | $14.7M | $60.4M | $54.5M | $19.5M | $50.8M | $54.0M |
| Beneficio Operativo | -$7.7M | -$23.2M | -$38.7M | -$36.8M | -$45.0M | -$43.7M | -$53.2M | -$52.1M | -$41.5M | -$26.5M |
| EBITDA | -$7.5M | -$22.8M | -$37.9M | -$36.0M | -$44.0M | -$45.4M | -$50.5M | -$46.1M | -$37.5M | -$22.3M |
| Gastos por Intereses | 0 | 0 | 0 | 0 | 0 | 0 | $713815 | $1.2M | $796000 | $357000 |
| Beneficio Antes de Impuestos | -$7.7M | -$23.2M | -$38.2M | -$36.3M | -$44.6M | -$43.7M | -$53.0M | -$50.7M | -$40.7M | -$26.1M |
| Impuestos | 0 | 0 | $825000 | $412500 | $206250 | $495000 | 0 | 0 | 0 | $500000 |
| Beneficio Neto | -$7.7M | -$23.2M | -$39.0M | -$36.7M | -$44.8M | -$44.2M | -$53.0M | -$50.7M | -$40.7M | -$26.6M |
| BPA | $-11.10 | $-33.90 | $-58.20 | $-49.80 | $-46.80 | $-42.30 | $-44.70 | $-33.30 | $-21.60 | $-8.40 |
| BPA Diluido | $-11.10 | $-33.90 | $-58.20 | $-49.80 | $-46.80 | $-42.30 | $-44.70 | $-33.30 | $-21.60 | $-8.40 |
| Acciones en Circulación (Diluidas) | $688020 | $688020 | $671135 | $734726 | $956287 | $1.0M | $1.2M | $1.5M | $1.9M | $3.2M |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $14.9M | $63.5M | $20.8M | $44.3M | $74.9M | $64.4M | $51.6M | $48.5M | $22.5M | $27.1M |
| Inversiones a Corto | $50033 | $50068 | $18.4M | $15.1M | $10.0M | 0 | $24.7M | 0 | 0 | 0 |
| Cuentas por Cobrar | 0 | 0 | 0 | $754898 | $1.4M | $3.1M | $57000 | $1.7M | $945000 | $7.4M |
| Inventario | 0 | $225500 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $15.1M | $65.1M | $40.6M | $61.0M | $87.5M | $68.5M | $77.2M | $51.5M | $25.1M | $37.0M |
| Inmovilizado Material | $1.0M | $1.7M | $2.8M | $7.2M | $8.9M | $11.9M | $10.7M | $7.1M | $4.8M | $4.3M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | $175000 | 0 | $11667 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $16.3M | $67.0M | $45.4M | $71.6M | $99.5M | $83.4M | $91.3M | $61.5M | $32.2M | $42.2M |
| Cuentas por Pagar | $523811 | $1.3M | $2.0M | $882666 | $2.1M | $2.6M | $2.7M | $3.5M | $2.8M | $3.9M |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | $2.0M | $2.0M | $4.0M | $4.3M | 0 |
| Pasivos Corrientes | $1.1M | $5.3M | $6.2M | $11.7M | $16.3M | $12.8M | $11.5M | $17.1M | $13.7M | $13.5M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | $8.0M | $4.2M | 0 | 0 |
| Pasivos Totales | $1.1M | $5.3M | $11.4M | $17.0M | $20.6M | $17.9M | $25.6M | $24.4M | $14.7M | $15.8M |
| Reservas | -$9.6M | -$32.8M | -$71.8M | -$108.5M | -$153.3M | -$197.4M | -$250.5M | -$301.2M | -$341.9M | -$368.5M |
| Patrimonio Neto | $15.2M | $61.6M | $34.0M | $54.6M | $78.9M | $65.5M | $65.7M | $37.1M | $17.5M | $26.4M |
| Deuda Total | 0 | $2.5M | 0 | $5.8M | $7.1M | $12.0M | $19.3M | $14.7M | $8.9M | $4.2M |
| Deuda Neta | -$15.0M | -$61.1M | -$39.2M | -$53.6M | -$77.7M | -$52.3M | -$57.0M | -$33.8M | -$13.6M | -$22.9M |
| Capital Circulante | $14.1M | $59.7M | $34.4M | $49.4M | $71.2M | $55.7M | $65.6M | $34.4M | $11.4M | $23.5M |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Beneficio Neto | -$7.7M | -$23.2M | -$39.0M | -$36.7M | -$44.8M | -$44.2M | -$53.0M | -$50.7M | -$40.7M | -$26.6M |
| Amortizaciones | $202085 | $419568 | $760011 | $5.2M | -$3.1M | -$1.8M | $1.8M | $3.4M | $2.4M | $958000 |
| Compensación en Acciones | $889556 | $2.8M | $7.2M | $6.5M | $10.5M | $11.5M | $9.5M | $8.2M | $6.8M | $4.7M |
| Cambio en Capital Circulante | $532321 | $2.9M | $4.2M | -$1.5M | $5.4M | -$4.4M | $356000 | -$934000 | -$4.9M | -$3.3M |
| Flujo de Caja Operativo | -$6.0M | -$12.2M | -$26.4M | -$30.8M | -$32.5M | -$38.8M | -$41.8M | -$40.0M | -$36.3M | -$21.7M |
| Inversiones (CapEx) | -$515979 | -$1.2M | -$1.9M | -$46353 | -$595259 | -$913039 | -$171000 | 0 | -$66000 | -$177000 |
| Adquisiciones | 0 | 0 | 0 | $127500 | 0 | 0 | 0 | 0 | 0 | $40000 |
| Recompra de Acciones | -$1.4M | -$4.2M | 0 | -$91027 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$6.5M | -$13.4M | -$28.3M | -$30.8M | -$33.1M | -$39.8M | -$42.0M | -$40.0M | -$36.4M | -$21.9M |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Crecimiento Ingresos (anual) | +202.7% | -8.8% | +373.7% | -91.7% | +341.0% | +69.2% | +195.7% | |||
| Crecimiento Beneficio Neto (anual) | -203.4% | -67.8% | +5.9% | -22.0% | +1.4% | -20.0% | +4.3% | +19.8% | +34.6% | |
| Crecimiento BPA (anual) | -205.4% | -71.7% | +14.4% | +6.0% | +9.6% | -5.7% | +25.5% | +35.1% | +61.1% | |
| Cambio en Acciones (anual) | +0.0% | -2.5% | +9.5% | +30.2% | +9.1% | +13.9% | +28.3% | +23.1% | +68.2% | |
| Crecimiento FCF (anual) | -106.6% | -111.0% | -9.1% | -7.3% | -20.1% | -5.6% | +4.8% | +8.9% | +39.9% | |
| Margen Bruto | -2398.2% | -694.8% | -963.5% | 111.9% | 100.0% | -593.9% | 100.0% | 100.0% | ||
| Margen Operativo | -3386.7% | -1063.2% | -1428.0% | -292.6% | -4275.1% | -949.9% | -446.9% | -96.6% | ||
| Margen EBITDA | -3320.2% | -1039.8% | -1394.4% | -304.1% | -4055.5% | -838.8% | -404.1% | -81.1% | ||
| Margen Neto | -3411.5% | -1061.2% | -1419.8% | -295.6% | -4257.8% | -924.1% | -438.0% | -96.9% | ||
| Margen FCF | -2473.8% | -891.9% | -1049.0% | -266.0% | -3371.6% | -727.9% | -391.9% | -79.6% | ||
| Tasa Impositiva Efectiva | -0.0% | -0.0% | -2.2% | -1.1% | -0.5% | -1.1% | -0.0% | -0.0% | -0.0% | -1.9% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| FCF por Acción | $-9.42 | $-19.47 | $-42.12 | $-41.98 | $-34.60 | $-38.12 | $-35.33 | $-26.20 | $-19.38 | $-6.92 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $688020 | $688020 | $671135 | $734726 | $956287 | $1.0M | $1.2M | $1.5M | $1.9M | $3.2M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -100.64% |
| Rentabilidad sobre capital invertido | -86.59% |
| Rentabilidad sobre activos | -63.02% |
| Margen bruto | 100.00% |
| Margen operativo | -96.56% |
| Margen neto | -96.85% |
Salud financiera
| Deuda / Patrimonio | 0.16 |
| Ratio corriente | 2.74 |
| Piotroski F-Score | 4 |
| Altman Z-Score | -11.88 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E | -31.43 | -10.29 | -2.42 | -9.56 | -8.02 | -8.02 | -1.91 | -2.38 | -1.51 | -1.09 |
| P/VC | 15.82 | 3.90 | 2.79 | 6.41 | 4.55 | 5.40 | 1.55 | 3.26 | 3.51 | 1.09 |
| P/V | 0.00 | 0.00 | 82.82 | 101.18 | 113.78 | 23.68 | 81.61 | 22.00 | 6.61 | 1.05 |
| Margen Bruto | 0.0% | 0.0% | -2398.2% | -694.8% | -963.5% | 111.9% | 100.0% | -593.9% | 100.0% | 100.0% |
| Margen Operativo | 0.0% | 0.0% | -3386.7% | -1063.2% | -1428.0% | -292.6% | -4275.1% | -949.9% | -446.9% | -96.6% |
| Margen Neto | 0.0% | 0.0% | -3411.5% | -1061.2% | -1419.8% | -295.6% | -4257.8% | -924.1% | -438.0% | -96.9% |
Empresas relacionadas: BRNS · COEP · EQ · IOBT · IPSC · MDCX · NRXP
Explorar sector: Healthcare · Biotechnology
Más secciones de CUE: Resumen · Valoración · Estadísticas · Estimaciones · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones